Physician

Mark Mclaughlin, M.D., PH.D.

According to 2025 Medicare claims, Mark Mclaughlin, M.D., PH.D. (NPI: 1386164507) practices radiation oncology in the Oklahoma City, OK market, with the plurality of this provider's patient population coming from Oklahoma, OK. This provider's primary affiliated billing organization is OKLAHOMA PROTON CENTER LLC (NPI: 1114408762; TIN: 611906834) and primary practice location at 73142-2015. Mclaughlin is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616) and Saint Francis Accountable Health Alliance LLC (ACO ID: A5372), participating under the MSSP model.

Mclaughlin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 457 traditional Medicare patients, billed 10,987 HCPCS/CPT codes, and received $2,617,422 in Medicare payments. The top billing code was 77523 (Intermediate proton beam radiation treatment). Part D data shows 371 prescription claims across 126 beneficiaries totaling $4,929 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 18 records totaling $1,114. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,237 to $4,929. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.